Macular Degeneration, Age-Related
Showing 1 - 25 of >10,000
VeriSee AMD in Screening for Age-Related Macular Degeneration
Completed
- Macular Degeneration, Age Related
- Maculopathy, Age Related
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 23, 2022
Macular Degeneration, Age Related, Cataract Trial (NGenuity)
Not yet recruiting
- Macular Degeneration, Age Related
- Cataract
- NGenuity
- (no location specified)
Aug 3, 2023
Macular Degeneration, Age Related, Geographic Atrophy Trial in Madison (Spectralis FAF imaging, Optos imaging, Zeiss Clarus 700
Not yet recruiting
- Macular Degeneration, Age Related
- Geographic Atrophy
- Spectralis FAF imaging
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Jul 18, 2023
Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)
Recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept 40 MG/ML
- Faricimab 120 MG/ML
-
Graz, Styria, AustriaDepartment of Ophthalmolgy, Medical University Graz
Jul 3, 2023
Preparation of Patient Autologous Induced Pluripotent Stem
Not yet recruiting
- Age-Related Macular Degeneration
- somatic cell collection
- (no location specified)
Aug 14, 2023
Neovascular Age-related Macular Degeneration Trial (RRG001)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- (no location specified)
Nov 15, 2023
Intestinal Microbiome in Wet Age-related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
- Sample examination
-
Ioánnina, Epirus, Greece
- +1 more
Feb 23, 2023
Rehabilitating Vision Loss in Veterans With Age-Related Macular
Not yet recruiting
- Age-related Macular Degeneration (AMD)
- Study-specific rehabilitation (SSR) procedures
-
Augusta, GeorgiaCharlie Norwood VA Medical Center, Augusta, GA
Mar 10, 2023
Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)
Recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, ArizonaRetinal Research Institute, LLC
Jun 4, 2023
Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)
Not yet recruiting
- Age-Related Macular Degeneration
- NG101 AAV gene therapy
-
Toronto, Ontario, CanadaVitreous Retina Macula Specialists of Toronto
Aug 2, 2023
Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)
Recruiting
- Age-Related Macular Degeneration
- VOY-101
-
Sydney, New South Wales, Australia
- +3 more
Oct 17, 2023
Single Injection of Faricimab for nAMD With Persisting Fluid
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Glostrup, DenmarkMiklos Schneider
Nov 3, 2023
Neovascular Age-related Macular Degeneration Trial (PMC-403)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- (no location specified)
Jul 11, 2023
Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])
Not yet recruiting
- Age-related Wet Macular Degeneration
- CG-P5 peptide
- +2 more
-
Augusta, Georgia
- +3 more
Nov 13, 2023
Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- AXT107 Low Dose
- +2 more
- (no location specified)
May 5, 2023
Progression of Early Atrophic Lesions
Not yet recruiting
- Age-Related Macular Degeneration
- No intervention
-
Salt Lake City, UtahUniversity of Utah
Jul 26, 2023
Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept Ophthalmic
- IBI302
-
Suzhou, Jiangsu, ChinaInnovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023
Age-Related Macular Degeneration Trial in Worldwide (Yellow and red light emitting diode photobiomodulation (Eye Light,
Recruiting
- Age-Related Macular Degeneration
- Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
- Sham Mask
-
Paris, France
- +6 more
Sep 14, 2023
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
Impact of Non-Exudative Type 1 MNV on AMD Progression
Recruiting
- Age-Related Macular Degeneration
- Neovascularization, Choroidal
-
Salt Lake City, UtahUniversity of Utah
Nov 15, 2023
Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- OCU-10-C-110 for Injection
-
Abilene, TexasRetina Research Institute of Texas
Jun 6, 2023
Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- AR-14034 SR implant lower dose
- +3 more
- (no location specified)
Mar 3, 2023
Age-Related Macular Degeneration Trial in Rotterdam (Standard lifestyle recommendations + dietary supplementation, Risk
Recruiting
- Age-Related Macular Degeneration
- Standard lifestyle recommendations + dietary supplementation
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Center
Dec 19, 2022
Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia
Not yet recruiting
- Macular Degeneration, Age Related
- +4 more
- VISUPRIME
- Placebo
-
Perugia, PG, ItalyOspedale Santa Maria della Misericordia
Dec 22, 2022
Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)
Completed
- Age-related Macular Degeneration
- Blood draw and urine collection
-
Coimbra, PortugalAIBILI
Jan 6, 2023